Document Detail


A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.
MedLine Citation:
PMID:  15924594     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
One option for patients with symptoms of gastroesophageal reflux disease (GERD) is treatment with proton pump inhibitors without prior endoscopy. Continuous or on-demand maintenance therapy are options for symptom-free patients. This study assessed the efficacy of three different treatment options in GERD patients in Norway. About 395 General Practitioners enrolled 2156 patients with symptoms of GERD in an open, randomised, parallel group trial. Following a 4-week symptom control phase [esomeprazole 40 mg once daily (od)], patients received either esomeprazole 20 mg od continuously or on-demand or ranitidine 150 mg twice-daily continuously for 6 months. The percentage of patients with no heartburn at the end of the study was maintained most effectively in the esomeprazole 20 mg continuous group (72.2%) and least effectively in the ranitidine group (32.5%). Significantly, more patients were completely/very satisfied with esomeprazole continuous (82.2%) and esomeprazole on-demand (75.4%) than with ranitidine continuous (33.5%) treatment (p < 0.0001). More patients were kept in remission, symptom free and were overall more satisfied with esomeprazole treatment than ranitidine.
Authors:
A Norman Hansen; R Bergheim; H Fagertun; H Lund; B Moum
Related Documents :
2510264 - Treatment of benign gastric ulcer: a comparative clinical trial of rioprostil and ranit...
2902494 - Effect of cimetidine on survival after gastric cancer.
6853984 - Cimetidine for recurrent ulcer after gastric surgery.
3311954 - Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. italian multi...
8187254 - A comparison of lumbar epidural and intravenous fentanyl infusions for post-thoracotomy...
18082204 - Biofeedback therapy and home pelvic floor exercises for lower urinary tract dysfunction...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  International journal of clinical practice     Volume:  59     ISSN:  1368-5031     ISO Abbreviation:  Int. J. Clin. Pract.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-31     Completed Date:  2005-08-18     Revised Date:  2013-01-07    
Medline Journal Info:
Nlm Unique ID:  9712381     Medline TA:  Int J Clin Pract     Country:  England    
Other Details:
Languages:  eng     Pagination:  665-71     Citation Subset:  IM    
Affiliation:
Harbitzallèen Legesenter, Oslo, Norway. age.normanhansen@harbitzalleen.onh.no
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Ulcer Agents / administration & dosage*
Drug Administration Schedule
Esomeprazole Sodium / administration & dosage*
Female
Gastroesophageal Reflux / drug therapy*
Humans
Long-Term Care
Male
Middle Aged
Norway
Patient Satisfaction
Prospective Studies
Proton Pumps / antagonists & inhibitors*
Chemical
Reg. No./Substance:
0/Anti-Ulcer Agents; 0/Proton Pumps; L2C9GWQ43H/Esomeprazole Sodium
Comments/Corrections
Erratum In:
Int J Clin Pract. 2005 Nov;59(11):1371

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Six-month management of patients following treatment for gastroesophageal reflux disease symptoms --...
Next Document:  D2 gastrectomy -- a safe operation in experienced hands.